symbol,statement_type,period_end,line_item,value
CONCORDBIO.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.248529
CONCORDBIO.NS,income,2025-03-31 00:00:00,Normalized EBITDA,5494561000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Total Unusual Items,
CONCORDBIO.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
CONCORDBIO.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,3716423000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,543735000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,3055131000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,EBITDA,5494561000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,EBIT,4950826000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Net Interest Income,-5293000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Interest Expense,5293000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Interest Income,
CONCORDBIO.NS,income,2025-03-31 00:00:00,Normalized Income,3716423000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,3716423000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Total Expenses,7481289000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
CONCORDBIO.NS,income,2025-03-31 00:00:00,Diluted Average Shares,
CONCORDBIO.NS,income,2025-03-31 00:00:00,Basic Average Shares,
CONCORDBIO.NS,income,2025-03-31 00:00:00,Diluted EPS,
CONCORDBIO.NS,income,2025-03-31 00:00:00,Basic EPS,
CONCORDBIO.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,3716423000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,3716423000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Net Income,3716423000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,3716423000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,3716423000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Tax Provision,1229110000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Pretax Income,4945533000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,444467000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Special Income Charges,
CONCORDBIO.NS,income,2025-03-31 00:00:00,Other Special Charges,
CONCORDBIO.NS,income,2025-03-31 00:00:00,Write Off,
CONCORDBIO.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-5293000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Total Other Finance Cost,
CONCORDBIO.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,5293000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
CONCORDBIO.NS,income,2025-03-31 00:00:00,Operating Income,4519580000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Operating Expense,4426158000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Other Operating Expenses,2493087000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,543735000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Amortization,
CONCORDBIO.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,543735000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Selling General And Administration,
CONCORDBIO.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,
CONCORDBIO.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
CONCORDBIO.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
CONCORDBIO.NS,income,2025-03-31 00:00:00,Gross Profit,8945738000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Cost Of Revenue,3055131000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Total Revenue,12000869000.0
CONCORDBIO.NS,income,2025-03-31 00:00:00,Operating Revenue,12000869000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.253201
CONCORDBIO.NS,income,2024-03-31 00:00:00,Normalized EBITDA,4687084000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Total Unusual Items,142180000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,142180000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,3081032000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,535915000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,2291981000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,EBITDA,4687084000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,EBIT,4151169000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Net Interest Income,-25519000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Interest Expense,25519000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Interest Income,30411000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Normalized Income,3081032000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,3081032000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Total Expenses,6389736000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,85581000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Diluted Average Shares,104619083.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Basic Average Shares,104619083.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Diluted EPS,29.45
CONCORDBIO.NS,income,2024-03-31 00:00:00,Basic EPS,29.45
CONCORDBIO.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,3081032000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,3081032000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Net Income,3081032000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,3081032000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,3081032000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Tax Provision,1044618000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Pretax Income,4125650000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,337800000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Special Income Charges,1533000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Other Special Charges,-1533000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Write Off,
CONCORDBIO.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-25519000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Total Other Finance Cost,6321000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,25519000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,30411000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Operating Income,3779656000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Operating Expense,4097755000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Other Operating Expenses,2331373000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,535915000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Amortization,3388000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,535915000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Selling General And Administration,442383000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,331096000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,General And Administrative Expense,111287000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,85581000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Gross Profit,7877411000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Cost Of Revenue,2291981000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Total Revenue,10169392000.0
CONCORDBIO.NS,income,2024-03-31 00:00:00,Operating Revenue,10169392000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,10863104.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.256
CONCORDBIO.NS,income,2023-03-31 00:00:00,Normalized EBITDA,3763127000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Total Unusual Items,42434000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,42434000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,2400857000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,540324000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,1970667000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,EBITDA,3805561000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,EBIT,3265237000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Net Interest Income,-7437000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Interest Expense,45103000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Interest Income,44408000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Normalized Income,2369286104.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,2400857000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Total Expenses,5258865000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,58980000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Diluted Average Shares,104616204.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Basic Average Shares,104616204.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Diluted EPS,22.949189
CONCORDBIO.NS,income,2023-03-31 00:00:00,Basic EPS,22.949189
CONCORDBIO.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,2400857000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,2400857000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Net Income,2400857000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,2400857000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,2400857000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Tax Provision,819277000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Pretax Income,3220134000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,15872000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Special Income Charges,5265000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Other Special Charges,-5265000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Write Off,0.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,-7437000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Total Other Finance Cost,6742000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,45103000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,44408000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Operating Income,3047457000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Operating Expense,3288198000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Other Operating Expenses,1551033000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,540324000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Amortization,33794000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,506530000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Selling General And Administration,342004000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,236985000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,General And Administrative Expense,105019000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,58980000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Gross Profit,6335655000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Cost Of Revenue,1970667000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Total Revenue,8306322000.0
CONCORDBIO.NS,income,2023-03-31 00:00:00,Operating Revenue,8306322000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,-2516425.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.2635
CONCORDBIO.NS,income,2022-03-31 00:00:00,Normalized EBITDA,2940070000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Total Unusual Items,-9550000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-9550000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,1749290000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,500500000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,1779230000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,EBITDA,2930520000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,EBIT,2430020000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Net Interest Income,-13480000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Interest Expense,54840000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Interest Income,47870000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Normalized Income,1756323575.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,1749290000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Total Expenses,4723130000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,20000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Diluted Average Shares,104616204.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Basic Average Shares,104616204.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Diluted EPS,16.721023
CONCORDBIO.NS,income,2022-03-31 00:00:00,Basic EPS,16.721023
CONCORDBIO.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,1749290000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,1749290000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Net Income,1749290000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,1749290000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,1749290000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Tax Provision,625890000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Pretax Income,2375180000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,9730000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Special Income Charges,-61850000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Other Special Charges,-2690000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Write Off,64540000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,-13480000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Total Other Finance Cost,6510000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,54840000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,47870000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Operating Income,2361270000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Operating Expense,2943900000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Other Operating Expenses,1264900000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,500500000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Amortization,33950000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,466550000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Selling General And Administration,320170000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,214360000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,General And Administrative Expense,105810000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,20000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Gross Profit,5305170000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Cost Of Revenue,1779230000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Total Revenue,7084400000.0
CONCORDBIO.NS,income,2022-03-31 00:00:00,Operating Revenue,7084400000.0
CONCORDBIO.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Total Unusual Items,65010000.0
CONCORDBIO.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,65010000.0
CONCORDBIO.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
CONCORDBIO.NS,income,2021-03-31 00:00:00,EBITDA,
CONCORDBIO.NS,income,2021-03-31 00:00:00,EBIT,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Net Interest Income,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Interest Expense,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Interest Income,17870000.0
CONCORDBIO.NS,income,2021-03-31 00:00:00,Normalized Income,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Total Expenses,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,40000.0
CONCORDBIO.NS,income,2021-03-31 00:00:00,Diluted Average Shares,104616204.0
CONCORDBIO.NS,income,2021-03-31 00:00:00,Basic Average Shares,104616204.0
CONCORDBIO.NS,income,2021-03-31 00:00:00,Diluted EPS,22.452258
CONCORDBIO.NS,income,2021-03-31 00:00:00,Basic EPS,22.452258
CONCORDBIO.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Net Income,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Tax Provision,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Pretax Income,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Special Income Charges,-4850000.0
CONCORDBIO.NS,income,2021-03-31 00:00:00,Other Special Charges,-30000.0
CONCORDBIO.NS,income,2021-03-31 00:00:00,Write Off,4880000.0
CONCORDBIO.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Total Other Finance Cost,3810000.0
CONCORDBIO.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,17870000.0
CONCORDBIO.NS,income,2021-03-31 00:00:00,Operating Income,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Operating Expense,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Other Operating Expenses,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Amortization,32580000.0
CONCORDBIO.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Selling General And Administration,204570000.0
CONCORDBIO.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,133630000.0
CONCORDBIO.NS,income,2021-03-31 00:00:00,General And Administrative Expense,70940000.0
CONCORDBIO.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,40000.0
CONCORDBIO.NS,income,2021-03-31 00:00:00,Gross Profit,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Total Revenue,
CONCORDBIO.NS,income,2021-03-31 00:00:00,Operating Revenue,
